The Effect of Intradialytic Combined Exercise on Physical Outcomes in End-Stage Renal Disease Patients
Construction and Empirical Study of Exercise Program in Maintenance Hemodialysis Patients
1 other identifier
interventional
44
1 country
1
Brief Summary
Hemodialysis (HD) is an important and commonly used renal replacement therapy (RRT) for End-Stage Renal Disease (ESRD) patients worldwide. Inadequate HD, impaired exercise capacity and declined peripheral muscular strength resulted by HD and ESRD are still disturbing problems, which also predicts poor renal prognosis and poor quality of life. The results of systematic reviews by the investigators have shown that aerobic exercise and combined exercise can improve dialysis efficacy (alleviate uremia symptoms), improve aerobic exercise capacity and muscle strength, and improve patients' quality of life, which also supports the notion that the National Kidney Foundation Disease Outcomes Quality Initiative (K/DOQI) recommends exercise as cornerstone of ESRD rehabilitation. Therefore, this study used the effective exercise type of the systematic review results - combined exercise as an intervention method to observe its effects on dialysis efficacy, blood pressure, aerobic exercise capacity, muscle strength and quality of life. The study hypothesized that combined exercise can not only improve dialysis efficacy, but also has an interaction effect with intervention duration, which deserves researches' attention. Combined exercise will also improve blood pressure (including systolic blood pressure and diastolic blood pressure) in patients with ESRD and reduce the symptoms of renal hypertension. It will also improve the exercise capacity and muscle strength of ESRD patients and improve their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2019
CompletedFirst Submitted
Initial submission to the registry
September 25, 2019
CompletedFirst Posted
Study publicly available on registry
October 11, 2019
CompletedNovember 26, 2019
November 1, 2019
6 months
September 25, 2019
November 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Dialysis Efficacy (sp Kt/V)
Sp Kt/V is a dimensionless, mathematical representation of serum urea clearance, monitored by On-Line Clearance Monitor (OCM)-equipped Fresenius 4008-S machines (Fresenius, Bad Homburg, Germany).
sp Kt/V was measured at baseline (before intervention) and after 24 weeks of intervention.
Dialysis Efficacy (sp Kt/V)
Sp Kt/V is a dimensionless, mathematical representation of serum urea clearance, monitored by On-Line Clearance Monitor (OCM)-equipped Fresenius 4008-S machines (Fresenius, Bad Homburg, Germany).
sp Kt/V was measured after 4, 8, 12, 16 and 20 weeks of intervention for observing the effects of intervention and time on sp Kt/V more accurately.
Secondary Outcomes (5)
Blood Pressure (including systolic blood pressure (SBP) and diastolic blood pressure (DBP))
BP was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.
Six-minute walk test (6MWT)
6MWT was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.
5-repetition sit-to-stand test (STS 5)
The STS-5 was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.
30-second sit-to-stand test (STS 30)
The STS-30 was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.
Kidney Disease Quality of Life (KDQOL-36)
The KDQOL-36TM was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.
Study Arms (2)
Stand of Care
SHAM COMPARATORPatients in the control group received usual care with sham exercise.
Combined Exercise
EXPERIMENTALThe intervention was a 24-week progressive intradialytic combined cycling exercise which proceed in the first HD 2 hours. Each exercise lasted about 40 minutes.
Interventions
Patients in the control group received usual care and were advised to do sham exercise such as stretch legs and arms about 15 minutes during the first 2 HD hours.
Each session consisted of a 5-minute warm-up, cool-down and 30-minute cycling at a Rating of Perceived Exertion (RPE) of 12-14. The machine has two exercise types including aerobic exercise and resistance exercise. Patients were asked to perform aerobic exercise 20-min and resistance exercise 10-min in the first stage. Every four weeks is divided into a stage. And the time of aerobic exercise and resistance exercise were personally adjusted per stage to maintain the personalized target RPE. In the following stages, aerobic exercise was continued 15-min for the second stage, 10-min for the third and the forth stage, 15-min for the fifth stage and 20-min for the last stage. And the time for resistance exercise was adjusted for the total exercise time. The resistance of exercise also progressive increased in order to adapt the target RPE. It was accessible to patients of different ages, gender, cultures and ethnicities.
Eligibility Criteria
You may qualify if:
- Adult (age≥18) with stable ESRD.
- Receiving≥3 months HD.
- HD 3 times per week.
- Volunteer for participating this trial.
You may not qualify if:
- Unable to exercise (severe musculoskeletal pain at rest or with minimal activity precluding walking or stationary cycling; unable to sit, stand or walk unassisted) (walking device such as cane or walker allowed).
- Had shortness of breath at rest or with activities of daily living (NYHA Class IV).
- Had mental disease, disturbance of consciousness and couldn't cooperate with investigations and exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aili Lv, Doctor
Xi'an Jiaotong University Health Science Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients in the HD centers were randomly assigned to one of two wards at the time that they began to HD in this center. And in order to avoid contamination, randomization in this study was in accordance with the centers to which patients were assigned. Every HD center was randomized to either continue on usual HD care (control group) or intervention of intradialytic combined exercise based on usual HD care (intervention group).
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- student
Study Record Dates
First Submitted
September 25, 2019
First Posted
October 11, 2019
Study Start
March 11, 2019
Primary Completion
September 17, 2019
Study Completion
September 17, 2019
Last Updated
November 26, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share